Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/stockstowatch/public_html/wp-content/mu-plugins/GrULw0.php on line 4

Notice: Undefined index: HTTP_ACCEPT_LANGUAGE in /home/stockstowatch/public_html/wp-content/mu-plugins/GrULw0.php on line 4
Why Theratechnologies (THTX) Shares Are Trading Higher Today – Theratechnologies (NASDAQ:THTX) – Stocks to Watch
  • Thu. Apr 25th, 2024
Top Tags
Investing

Why Theratechnologies (THTX) Shares Are Trading Higher Today – Theratechnologies (NASDAQ:THTX)

ByVandana Singh

Nov 17, 2022
Why Theratechnologies (THTX) Shares Are Trading Higher Today - Theratechnologies (NASDAQ:THTX)

[ad_1]

  • Cantor Fitzgerald has initiated coverage on Theratechnologies Inc THTX with an Overweight rating and a price target of $9. 

  • Theratechnologies’ two HIV drugs, Egrifta and Trogarzo, could grow 20% a year for the foreseeable future, the analyst writes.

  • Being conservative, Cantor has modeled a mid-teens sales growth for these two products. 

  • Product innovations and dedicated sales focus on these two drugs have driven uptake. 

  • THTX’s decision to internalize its field force and strengthen its commercial operations in the U.S. is starting to deliver results, as evidenced by the 19% Y/Y sales growth in this territory in 3Q22. 

  • For FY22, the company says it is on track to be around $79 million – $82 million, or growth of the commercial portfolio of 13%-17% Y/Y.

  • Cantor writes that the company’s HIV franchise is a source of funds to help build its oncology and NASH pipelines.

  • In July, Theratechnologies issued an update on the dose escalation portion of the TH1902 Phase 1 safety study. 

  • The data came from 18 heavily pretreated patients with sortilin- (SORT1) expressing cancers.

  • No Dose Limiting Toxicities were observed during the first cycle.

  • Price Action: THTX shares are up 18.60% at $2.23 on the last check Thursday.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

[ad_2]

Image and article originally from www.benzinga.com. Read the original article here.

Vandana Singh

Related Post

Investing
AngioDynamics (ANGO) Q3 Earnings Lag Estimates, FY23 View Cut
Mar 31, 2023 Zacks
Investing
Your Parents Demand Financial Support, But You Suspect They’re Spending It Irresponsibly: What Do You Do?
Mar 31, 2023 AJ Fabino
Investing
San Francisco Fed leader Daly likely not major player in SVB saga, officials say
Mar 31, 2023 anna

You missed

Stocks
Technology
Commodities
Crypto